全文获取类型
收费全文 | 35773篇 |
免费 | 2114篇 |
国内免费 | 93篇 |
专业分类
耳鼻咽喉 | 385篇 |
儿科学 | 843篇 |
妇产科学 | 1245篇 |
基础医学 | 5296篇 |
口腔科学 | 914篇 |
临床医学 | 3385篇 |
内科学 | 6795篇 |
皮肤病学 | 748篇 |
神经病学 | 3638篇 |
特种医学 | 1817篇 |
外国民族医学 | 3篇 |
外科学 | 5274篇 |
综合类 | 246篇 |
一般理论 | 40篇 |
预防医学 | 2093篇 |
眼科学 | 786篇 |
药学 | 2381篇 |
中国医学 | 81篇 |
肿瘤学 | 2010篇 |
出版年
2021年 | 490篇 |
2020年 | 310篇 |
2019年 | 519篇 |
2018年 | 648篇 |
2017年 | 504篇 |
2016年 | 616篇 |
2015年 | 657篇 |
2014年 | 952篇 |
2013年 | 1301篇 |
2012年 | 1886篇 |
2011年 | 1929篇 |
2010年 | 1146篇 |
2009年 | 1121篇 |
2008年 | 1686篇 |
2007年 | 1867篇 |
2006年 | 1980篇 |
2005年 | 1868篇 |
2004年 | 1605篇 |
2003年 | 1637篇 |
2002年 | 1568篇 |
2001年 | 844篇 |
2000年 | 833篇 |
1999年 | 676篇 |
1998年 | 446篇 |
1997年 | 371篇 |
1996年 | 275篇 |
1995年 | 281篇 |
1994年 | 221篇 |
1993年 | 265篇 |
1992年 | 446篇 |
1991年 | 393篇 |
1990年 | 416篇 |
1989年 | 383篇 |
1988年 | 361篇 |
1987年 | 357篇 |
1986年 | 339篇 |
1985年 | 322篇 |
1984年 | 260篇 |
1983年 | 227篇 |
1982年 | 200篇 |
1981年 | 188篇 |
1979年 | 252篇 |
1978年 | 173篇 |
1977年 | 178篇 |
1976年 | 165篇 |
1975年 | 195篇 |
1974年 | 216篇 |
1973年 | 187篇 |
1972年 | 180篇 |
1970年 | 177篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Karl Johnson Katherine W. Saylor Isabella Guynn Karen Hicklin Jonathan S. Berg Kristen Hassmiller Lich 《Genetics in medicine》2022,24(2):262-288
PurposeUnderstanding the value of genetic screening and testing for monogenic disorders requires high-quality, methodologically robust economic evaluations. This systematic review sought to assess the methodological quality among such studies and examined opportunities for improvement.MethodsWe searched PubMed, Cochrane, Embase, and Web of Science for economic evaluations of genetic screening/testing (2013-2019). Methodological rigor and adherence to best practices were systematically assessed using the British Medical Journal checklist.ResultsAcross the 47 identified studies, there were substantial variations in modeling approaches, reporting detail, and sophistication. Models ranged from simple decision trees to individual-level microsimulations that compared between 2 and >20 alternative interventions. Many studies failed to report sufficient detail to enable replication or did not justify modeling assumptions, especially for costing methods and utility values. Meta-analyses, systematic reviews, or calibration were rarely used to derive parameter estimates. Nearly all studies conducted some sensitivity analysis, and more sophisticated studies implemented probabilistic sensitivity/uncertainty analysis, threshold analysis, and value of information analysis.ConclusionWe describe a heterogeneous body of work and present recommendations and exemplar studies across the methodological domains of (1) perspective, scope, and parameter selection; (2) use of uncertainty/sensitivity analyses; and (3) reporting transparency for improvement in the economic evaluation of genetic screening/testing. 相似文献
2.
Schneider Ralph Dettmer Marius Peters Nora Lamdark Tenzin Luedi Markus M. Adamina Michel Doll Dietrich 《European Surgery》2022,54(2):117-125
European Surgery - Treatment of pilonidal sinus disease (PSD) requires a tailored approach. A national guideline was published in 2014. The current status of surgical PSD therapy... 相似文献
3.
4.
5.
6.
7.
8.
9.
Daniel J. Snyder Thomas R. Kroshus Aakash Keswani Evan B. Garden Karl M. Koenig Kevin J. Bozic David S. Jevsevar Jashvant Poeran Calin S. Moucha 《The Journal of arthroplasty》2019,34(4):613-618
Background
Nursing Home Compare (NHC) ratings, created and maintained by Medicare, are used by both hospitals and consumers to aid in the skilled nursing facility (SNF) selection process. To date, no studies have linked NHC ratings to actual episode-based outcomes. The purpose of this study was to evaluate whether NHC ratings are valid predictors of 90-day complications, readmission, and bundle costs for patients discharged to an SNF after primary total joint arthroplasty (TJA).Methods
All SNF-discharged primary TJA cases in 2017 at a multihospital academic health system were queried. Demographic, psychosocial, and clinical variables were manually extracted from the health record. Medicare NHC ratings were then collected for each SNF. For patients in the Medicare bundle, postacute and total bundle cost was extracted from claims.Results
Four hundred eighty-eight patients were discharged to a total of 105 unique SNFs. In multivariate analysis, overall NHC rating was not predictive of 90-day readmission/major complications, >75th percentile postacute cost, or 90-day bundle cost exceeding the target price. SNF health inspection and quality measure ratings were also not predictive of 90-day readmission/major complications or bundle performance. A higher SNF staffing rating was independently associated with a decreased odds for >75th percentile 90-day postacute spend (odds ratio, 0.58; P = .01) and a 90-day bundle cost exceeding the target price (odds ratio = 0.69; P = .02) but was similarly not predictive of 90-day readmission/complications.Conclusion
Results of our study suggest that Medicare's NHC tool is not a useful predictor of 90-day costs, complications, or readmissions for SNFs within our health system. 相似文献10.
Mhd Wasem Alsabbagh Dana Church Lisa Wenger John Papastergiou Lalitha Raman-Wilms Eric Schneider Nancy Waite 《Research in social & administrative pharmacy》2019,15(2):202-206